Skip to main content
. 2020 Jan 14;13:1. doi: 10.1186/s40545-019-0198-6

Table 2.

Key dates and relevant protection periods for sofosbuvir, imatinib, and trastuzumab, based on SPCs granted in France [56, 64, 71]

Product Sofosbuvir Imatinib Trastuzumab
Year of market launch 2013 2001 1999
Year sales revenue surpassed R&D investment 2015 2003 2000
Basic patent expiry date 26/03/2028 25/03/2013 15/06/2012
SPC term > 9 months > 3 years 8 months > 2 years 1 month
SPC expiry date 17/01/2029 21/12/2016 29/07/2014